조회: 2682    [기사목록보기] 
평가-젤로다정500mg(카페시타빈, capecitabine 500mg):말초신경병증-평가 곤란(conditional/unclassified)
500mg(카페시타빈, capecitabine 500mg):말초신경병증-평가 곤란(conditional/unclassified)
약품 표준코드: 645000400


PharmPort
pharmport@naver.com